Asia Pacific Infusion
Pumps Market Overview:
The Asia Pacific Infusion Pumps market was estimated at USD
2,675 million in 2018 and is expected to witness market growth of 7% CAGR
during the forecast period of 2018 – 2025 to reach a value of USD 4,527 million.
The infusion pumps and accessories are a set of drugs
delivering devices that are used to administer medications in a controlled, automated manner and precise. These devices are for therapeutic purposes, and
come handy in critical care, pain management, and some other applications, to
administer medications on a continuous basis to ensure patients comfort and
also, offer pain-free therapy.
Browse details of 140
number of pages research report developed on Asia Pacific Infusion Pumps Market
Research Report @ https://www.researchcosmos.com/reports/asia-pacific-infusion-pumps-market/82613225
These infusion pumps include volumetric infusion syringes,
pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion
pumps, enteral infusion pumps, patient-controlled analgesia infusion pumps, and
implantable infusion pumps. During 2017, the insulin infusion pumps segment
dominated the Asia Pacific market and is expected to register the highest CAGR
during the forecast
period.
Drivers, Challenges,
and Opportunities of Asia Pacific Infusion Pumps Market:
Growing diabetes coupled with the growing demand for the
management of insulin at home, the prevalence of diabetes, is expected to drive
the growth of this regional market.
A number of primary factors such as the growing incidence of
chronic diseases along with demand for ambulatory infusion pumps, the rapid
growth in the geriatric population, rising and the increased volume of surgical
procedures performed are driving the infusion pumps market in the Asia Pacific.
Mounting demand for home-based healthcare solutions and
increasing levels of disposable income in the developing economies are expected
to supplement the market growth. Additionally, Stringent government regulations
for the approval of devices and lack of cybersecurity in wireless infusion
pumps are expected to limit the growth significantly.
Ask Free Sample of
the Report @ https://www.researchcosmos.com/request/asia-pacific-infusion-pumps-market/82613225
Geographic Analysis of Asia Pacific Infusion Pumps Market
In the Asia-Pacific insulin infusion pumps market, China
accounted for close to 72% of the market value in 2018. By 2024, the market in
China is likely to be valued at USD 0.9 billion. Malaysia and Vietnam account
for the highest CAGR of 7% and 6%, respectively, in the market studied.
In addition, untapped, emerging markets such as India and
China and the growing adoption of specialty infusion pumps are offering
significant growth opportunities for players operating in the regional market.
Some of the Key Players Covered in this Asia Pacific Infusion Pumps
Market are:
The market is highly competitive with the presence of
several small and major key players. Key companies profiled in the report
include Dickinson and Company, B. Braun Melsungen AG, Becton, Baxter
International Inc., Pfizer Inc., CEMEX Inc., Hoffmann-la Roche Ltd., Medtronic,
Inc., Terumo Corporation, and Smiths Medical.
For any queries,
inquire more @ https://www.researchcosmos.com/inquire/asia-pacific-infusion-pumps-market/82613225
About Us:
Research Cosmos is a provider of standard and customized
Industry research, business intelligence and consulting services across more
than 100 domains in different industries of the world. We host the trending
Industry reports of the world’s top-notch publishing companies, offering
services to a wide range of customers from students to fortune 500 companies
and discloses the hidden opportunities in every leading industry of the world.
Contact:
Kevin Stewart
kevin@researchcosmos.com
Global Sales Manager
Research Cosmos
+1 888 709 8757
No comments:
Post a Comment